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ABSTRACT
The  use  of  light  to  control  the  expression  of  genes  and  the  activity  of
proteins is a rapidly expanding field. While many of these approaches use a
fusion between a light activable protein and the protein of interest to control
the activity of the later, it is also possible to control the activity of a protein
by uncaging a specific ligand. In that context, controlling the activation of a
protein fused to the modified estrogen receptor (ERT) by uncaging its ligand
cyclofen-OH has emerged as a generic and versatile method to control the
activation of proteins quantitatively, quickly and locally in a live organism.
We here present that approach and its  uses in a variety of  physiological
contexts.
Key  words:  Optogenetics,  Optical  control;  Cre-ERT,  caged  molecules,
cyclofen-OH
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INTRODUCTION
The cells in living organisms are dynamical systems capable of responding to
external  signals  by  modifying  their  internal  state  and  subsequently  their
external environment.  As for all dynamical systems, the best way to study
them is to investigate their response to local spatio-temporal perturbations1.
To  investigate  these  dynamical  processes  in  a  live  organism,  various
methods (gathered under the term of optogenetics) have been developed to
spatially  and  temporally  perturb  these  processes  using  light,  while
monitoring the cells’ response on a fast (sub-minute) timescale and single
cell resolution. To photocontrol the activity of proteins (and the expression of
genes), two main approaches have been adopted. One is  based on light-
sensitive proteins and the other on light-sensitive protein ligands. 
The first light-sensitive proteins to be used in an optogenetic context were
rhodopsins2,3,  which  consist  of  a  chromophore,  retinal  or  one  of  its
derivatives  bound  to  a  seven-domains  transmembrane  protein.  Upon
illumination,  the  bound  retinal  molecule  undergoes  photo-isomerization,
which  induces  conformational  changes  in  the  opsin  backbone.
Channelrhodopsins  4,5 conduct  cations  and  depolarize  neurons  upon  blue
light illumination, leading to neuronal activation. Conversely, halorhodopsins6
pump chloride ions into the cytoplasm upon yellow light illumination, leading
to  hyperpolarization  and  inhibition  of  neuronal  activity.  These  rhodopsins
allow for  control  of  neuronal  networks  in-vivo with unprecedented spatio-
temporal resolution (reviewed in 7-9).  
Following on these pioneering works,  various  light-sensitive proteins  were
adapted as a means to control the activity of fused proteins. Flavoproteins10-
12 attracted  particular  interest  because  of  their  riboflavin-based
chromophore,  either  flavin  adenine  dinucleotide  (FAD)  or  flavin
mononucleotide (FMN), which is naturally present in most cells. Three major
flavoproteins were used: light-, oxygen- or voltage-sensing (LOV) proteins13;
blue  light–utilizing  flavin  (BLUF)  proteins14;  and  the  light-sensitive
cryptochromes  (CRYs)15.  Another  two  systems  exploited  for  photo-
dimerization of fused proteins is the plant phytochromes (PHY)16 and UV-B
resistance 8  (UVR8)17.  In  these systems,  illumination  of  the  chromophore
induces  its  isomerization  and  triggers  a  protein  conformational  change,
which can be used to control the activity of a fusion protein either directly by
unmasking a protein  function  or  indirectly  through the control  of  protein-
protein interactions. 
These approaches based on the fusion between a protein of interest and a
light-sensitive one have the advantage of reversibility and genomic design.
However, to reduce leakage and improve signal to noise ratios may require
extensive tweaking of the fused complex.  Moreover,  the activation of  the
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fused protein sometimes requires prolonged illumination which defeats the
purpose  of  the  use  of  light  as  a  means  to  improve  spatio-temporal
resolution18. 
To address some of these issues,  another approach based on the use of
caged ligands has  been pursued by various  groups.  There  exists  a  large
variety of  small  molecules that  bind to specific proteins,  which are often
transcriptional activators. These small ligands (ecdysone, doxycycline, IPTG,
rapamycin,  tamoxifen-OH,  cyclofen-OH)  can  be  caged and  released  upon
illumination at an appropriate wavelength (often in the near UV - around 375
nm -  but  also  in  the  visible,  see  below).  Thus  a  caged  ecdysone19 was
developed  to  create  a  photo-inducible  gene  expression  system.  Upon
illumination, the caged ecdysteroid is rapidly converted into active ecdysone,
which binds and activates the ecdysone receptor, promoting its association
to a responsive element and inducing the expression of the gene under its
control. Similar systems were developed based on caged-IPTG20 (allowing for
photo-induction  of  genes  under  control  of  the  Lac  operator)  and  caged-
doxycycline21 (photo-inducing  the  expression  of  genes  under  the  Tet
operator). 
Other systems have been developed to control the activity of cytoplasmic
proteins.  Thus,  caged  rapamycin22,23 was  designed  to  promote  the  light-
induced heterodimerization of two proteins fused to FK-506 binding protein
(FKBP)  and  to  the  FKBP-rapamycin  binding  protein  (FRB),  enabling  the
photocontrol in live cells of signaling proteins (such as the small GTPase Rac
involved in membrane ruffling) and the regulation of the activity of protein
kinases. 
In the context of the control of cytoplasmic proteins, steroid hormones and
their receptors24,25 have long been used as tissue-specific inducible systems.
In absence of ligand, a protein fused to the hormone binding domain (and
expressed under a tissue-specific promoter) is sequestered by cytoplasmic
chaperones  and  therefore  usually  inactive.  Introduction  of  appropriate
steroids releases the fused protein from its chaperone complex and activates
its function. That approach was used to induce the activity of a great variety
of  proteins:  transcription  factors26-29 (such  as  Gal4,  GATA  or  c-Jun),
recombinases30,31(such  as  Flp  or  Cre),  kinases32 (such  as  Erb1  or  Src),
oncogenes 33,34(such as B-Raf or cMyc), tumor suppressors 35,36(such as p53)
and enzymes 37(such as -Galactosidase). The caging and subsequent photo-
release  of  steroid  hormones  thus  offers  a  versatile,  generic  and  proven
approach to the quick photo-control  of  the activity of many proteins at a
cellular level. 
The  advantage  of  caged  ligands  is  that  they  build  on  existing  inducible
systems  and  are  often  characterized  by  a  quick  localized  release  of  the
ligand.  However,  they  have  to  satisfy  demanding  physico-chemical
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constraints among which: 
- the caged compound has to be soluble and permeate the tissues
and the cells of the target organism; 
- the active uncaged molecule has to be stable when illuminated;
- the illumination  characteristics  (intensity,  wavelength,  time-lapse)
and both the caged inducer and the uncaged products have to be
non-toxic to the cells. 
A  drawback  of  caged  ligand  systems  is  that  they  are  irreversible.  Once
released they diffuse out and maybe degraded which limits their action in
both space and time (though in many cases this may be desired). Moreover,
issues of leakage and background activity (of the photo-activated protein)
have  to  be  addressed  separately  (for  example  by  controlling  the
concentrations of caged-ligand, chaperones and/or receptor). 
In the following we shall focus on a caged steroid we are most familiar with
(caged cyclofen),  which  we  have  used  in  a  live  animal  to  gain  a  better
understanding of a variety of physiological networks (cancer, somitogenesis,
apoptosis,  etc.).  The  lessons  learned  with  this  particular  hormone-like
molecule should be readily applicable to other steroids of the same family.  
The caged-cyclofen-OH/ERT system
Within the steroid class of activators, tamoxifen-OH has long been used as
the ligand of the estrogen receptor (ER) binding domain or more precisely,
the ERT peptide: a binding domain engineered to interact specifically with
tamoxifen-OH (in order to reduce possible interference with the endogenous
estrogen pathway38,39, one of the reason why caged-estradiol40 is not much
used). Tamoxifen-OH has been caged41-44, but its photochemical reactivity45,44
(isomerization) requires efficient caging groups46 and accurate control over
illumination for quantitative liberation41,42 which may complicate its use in
physiological  conditions47.  To  address  that  issue,  caged-cyclofen-OH48 has
been developed as a stable alternative to caged-tamoxifen-OH, see Fig.1.
Cyclofen-OH has similar affinity to the ERT binding domain as tamoxifen-OH,
is  stable  when  illuminated  and  is  easier  to  synthesize  (see  Supporting
Information).  
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Fig.1: The  caged-cyclofen-OH/ERT  system.  Proteins  fused  to  the  estrogen
receptor  (engineered  to  bind  specifically  to  tamoxifen-OH,  ERT)  are
sequestered  by  cytoplasmic  chaperones  (CC).  Illumination  of  caged  4,5-
dimethoxy-2-nitrobenzyl cyclofen-OH  (cCyc)  with  UV  (375  nm)  light  or
multiphoton  excitation  (at  750 and 1064  nm with  two-  and three-photon
excitation respectively) releases the hormone-like steroid cyclofen-OH (Cyc).
Its binding to the ERT domain releases the fused protein from its cytoplasmic
complex with chaperones. Adapted from Sinha et al.48.
We  first  caged  cyclofen-OH  with  4,5-dimethoxy-2-nitrobenzyl  alcohol,  6-
bromo-7-hydroxy-4-hydroxymethyl-coumarin  and  7-dimethyl-amino-4-
hydroxymethylcoumarin48,50.  In  particular,  the  4,5-dimethoxy-2-nitrobenzyl
caged cyclofen-OH has  been subsequently  used  in  biological  applications
where it has been successfully uncaged with one-, two-, and three-photon
excitations48,50,51.  Since  its  original  synthetic  pathway  was  not  compatible
with production at large scales, we subsequently simplified  its synthesis,
which is here reported as Supporting Information52. The present alternative
preparative  method  is  now  compatible  with  the  production  of  caged
precursors of cyclofen-OH up to the ten grams scale. Cyclofen-OH has been
subsequently caged with coumarin-based caging moieties absorbing up to
500 nm53. The resulting blue light absorbing caged cyclofen-OH enabled us to
achieve in living zebrafish embryos chromatic orthogonal photoactivation of
two biologically  active species  controlling  biological  development with UV
and blue-cyan light sources, respectively54. 
Proof of principle
To be of  any use  a  caged-ligand  system has  to  be  demonstrated in  the
animal model where it  will  be applied. Namely it must be shown to allow
control  of  protein  activity  or  gene  expression  at  the  single  cell  level.
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Transient  activation  must  be  characterized  and  permanent  activation
demonstrated (usually via the activation of a photo-controlled recombinase).
These proof-of-principle experiments are our subject next. 
The caged-cyclofen-OH/ERT system was first  tested in  model conditions48.
Thus a fusion construct (GFP-nls-ERT) between a nuclear localized GFP and
the ERT domain was injected in zebrafish embryos at the one-cell stage. The
embryos were incubated in caged cyclofen-OH and the GFP fluorescence was
observed to be diffused as expected from its cytoplasmic localization in a
complex with chaperones, see Fig.2(a). The embryos were then illuminated
for a few minutes with UV light (at 375nm), the cyclofen-OH was uncaged
and the GFP released from its chaperone complex diffused within 10-15min
into the cell nuclei, see Fig.2(b). Short (few seconds) two-photon illumination
of caged-cyclofen-OH was sufficient for its uncaging and was shown to lead
to the subsequent localization of GFP in the nucleus of the illuminated cell,
Fig.2(c). 
Fig.2: Photo-induction of GFP nuclear localization. A protein consisting of a 
GFP labeled with a nuclear localization signal (nls) is fused to the ERT 
domain. The mRNA of this construct (GFP-nls-ERT) is injected in zebrafish 
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embryos at the one-cell stage. (a) When the embryos are incubated in 
caged-cyclofen-OH, the GFP fluorescence is diffused as the construct is 
sequestered by cytoplasmic chaperones. (b) When they are illuminated with 
UV light, cyclofen-OH is released in the whole embryo, the GFP-nls-ERT 
protein construct is released from its chaperone complex and diffuses into 
the cells nuclei. (c) When illuminated with a two-photon laser for a few 
seconds, cyclofen-OH is released in a single cell and frees the GFP-nls-ERT 
protein in that cell only with subsequent increase in the fluorescence of that 
cell nucleus.   Adapted from Sinha et al.48.
In another set of experiments photo-activation via cyclofen-OH uncaging of a
Cre-ERT recombinase led to the irreversible excision of a GFP gene flanked
by loxP sites and the expression of a downstream dsRed gene50. Both global
activation by UV illumination and local activation by two-photon illumination
were demonstrated. In that case, it was shown that within one hour of photo-
activation, the recombinase had floxed 50% of its targets. That experiment
demonstrated the use of the caged-cyclofen-OH/ERT system for cell-specific
permanent genetic modifications and in particular cell labeling. 
To achieve transient genetic activation, we used a fusion between the ERT
domain and a transcription factor (Gal4) which can similarly be activated by
cyclofen-OH uncaging55. Diffusion of the transcription factor to the nucleus
activates genes under control of a UAS promoter. As the released cyclofen-
OH diffuses  out  of  the  cell,  the  Gal4-ERT proteins  are  re-sequestered  by
cytoplasmic  chaperones  and  the  transcription  activity  is  shut  off (which
incidentally might give access to the kinetics of transcription bursts). 
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Fig.3. Transient and permanent activation of a gene of interest (MyGene). (a)
Using UV or two-photon illumination, a Gal4-ERT construct is released (b) and
transiently activates a gene of interest under a UAS promoter. A fluorescent
CFP protein is used as a marker of activation while an EosFP serves as a
marker of expression of the genetic construct injected as a plasmid at one
cell stage. (c) Due to diffusion of the released cyclofen-OH, the activation of
transcription lasts a few hours, but the translated protein may linger for a
few  days.  (d)  Using  similar  illumination  on  a  Cre-ERT  construct  (e)  may
permanently label  a single cell  (shown here in red) since diffusion of  the
released cyclofen-OH will not alter the gene excision (e) performed by the
Cre-recombinase. This approach can be used to permanently activate a gene
of interest (f).  Adapted from Feng et al.55.
Applications in physiological contexts.
The caged-cyclofen-OH/ERT system has been used to control the expression
of genes and/or the activity of proteins in order to investigate a number of
physiological networks in various organisms. 
Tumorigenesis  is  supposed  to  originate  from  rare  single  cell  mutational
event(s), however the probability of tumorigenesis when a single oncogene
is turned on in a single cell has never been assessed. We decided to use our
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optogenetics  approach  to  address  that  issue.  Carcinogenesis was
investigated in zebrafish by initiating the expression of a single oncogene
(kRasG121V) in 2-3 days old embryos55. We showed that transient activation
of  the  oncogene,  Fig.3(a-c),  did  not  result  in  cancer  Fig.4(a-c),  whereas
permanent  activation,  Fig.3(d-f),  led  in  some  cases  to  tumors,  Fig.4(d-f)
albeit with a very low probability (about 0.5% of induced cells gave rise to a
tumor).  This  work  suggests  that  a  single  somatic  mutation  may  not  be
enough to initiate a tumor but that multiple factors (and mutations) maybe
required for  a single  cell  to  develop a tumor.  The caged-cyclofen-OH/ERT
system may help one address that issue by simultaneously inducing more
than one oncogene in one (or a few possibly confluent) cell(s) and in various
backgrounds (such as p53-/- and immuno-deficient embryos). 
Somitogenesis  was  also  investigated  using  the  caged-cyclofen-OH/ERT
system56.  In  this  instance,  we  were  interested  in  studying  the  network
sustaining the propagating wavefront in the clock and wavefront model of
somitogenesis49.  The expression of an exogenous Fgf8 was induced via the
activation  of  protein  fusion  between ERT  and  a  Gal4  transcription  factor
binding to a UAS promotor driving the expression of Fgf8. It was shown that
induction  of  Fgf8  expression  led  to  severe  developmental  defects  and  a
decrease in the size of somites, Fig.4(g,h). This assay allowed (in conjunction
with  more  established  approaches)  to  quantitatively  investigate   the
Godbeter-Pourquié model of the somitogenetic wavefront49. 
To  monitor  the  development  of  various  organs,  it  is  desirable  to  have  a
means to irreversibly label specific cells at a given developmental stage and
monitor  their  progeny.  The  optogenetic  method  described  here  is  ideally
suited to that purpose. The caged-cyclofen-OH/Cre-ERT system was used to
label  cell  clusters,  with  UV  light  (365nm)  in  a  mouse  context  (skin  and
mammary gland)57, and single cells with a 2-photon (750 nm) in zebrafish50,
see Fig.3(d) and with a 3-photon (1064nm) pulse-excitation in ~200 m deep
heart muscle of a zebrafish embryo51. These experiments demonstrate that
photo-activation of caged-cyclofen-OH can be implemented in a variety of
biological contexts using different illumination methods to label specific cells
in  the  animal.  These  experiments  open  the  way  for  cell  labeling  and
monitoring in live animals over extended periods of time. 
During embryonic development, many genes are involved at different time 
points and classical gain or loss of function by genetic approaches often fail 
to decipher protein function(s) at later stages of development58,59. Cyclofen-
OH release overtakes this problem by allowing protein activation at any 
chosen developmental stage. A good example is the homeoprotein Engrailed
2 (En2), known to be important for brain regionalization60,61, but which may 
interfere with earlier axis formation62. To decipher the time window during 
which En2 is active on the patterning of mesencephalic boundaries, we took 
advantage of the time-controlled activation of a fusion protein En2-ERT62. A 
10
mRNA coding En2-ERT was injected in zebrafish embryos at one cell stage 
and embryos incubated in caged-cyclofen-OH. Cyclofen-OH was then 
released upon time by one photon uncaging, and phenotypes were scored 48
hours post-fertilization. En2-ERT photo-activation prior to gastrulation 
induced a widespread insult resulting in abnormal axis and heart 
development defects in 40% of the embryos, while En2-ERT photoactivation 
at 50% and 70% epiboly impaired eye formation without any sign of axis 
abnormality. This impairment of eye formation (eye with reduced size or no 
eye phenotype) is clearly due to an expansion of the mesencephalon and a 
reciprocal reduction of the diencephalon. Later on, activation of En2-ERT at 
the beginning of somitogenesis (1- 2 somites) induced almost no phenotype. 
The time window at which En2 controls the diencephalic-mesencephalic 
boundary was thus defined in between 50% and 70% epiboly.
Another application is the activation of a protein that is deleterious for the 
cell. Apoptotic cells release signaling molecules that are of importance for 
developmental programs and homeostasis. Failure of apoptosis is one of the 
main contributions to tumour development and autoimmune diseases. To 
better understand this signaling pathway, one would like to induce apoptosis 
with a good spatiotemporal resolution, the ultimate goal being to do so at 
the single-cell level and at minute scale resolution. We took advantage of the
cascade of proteases involved in apoptosis and used a fusion between one of
the first protease in the cascade (Casp9) and the ERT domain63. The Casp9-
ERT fusion protein has no activity when expressed in zebrafish embryo but 
induces apoptotic cell death in the presence of cyclofen-OH. Using caged-
cyclofen-OH and two-photon uncaging allowed us to trigger apoptosis in a 
single cell of a developing embryo. 
Stop codon suppression (particularly the amber stop codon) has become a
popular strategy to introduce unnatural amino acids (Uaas) into a protein at
a specific site, which is commonly referred as the genetic code expansion.
The methodology involves the read-through of an amber stop codon inserted
into the gene of the targeted protein by a suppressor tRNA aminoacylated
with a desired Uaa. Varieties of Uaas containing side-chains that serve as
photoactive,  spectroscopic  and  redox  probes  have  been  successfully
introduced into proteins, which facilitate the development of novel detection
methods of specific protein function in vivo64,65. Recently, we and others have
generated zebrafish with the gene of orthogonal aminoacyl-tRNA synthetase
(RS)/suppressor  tRNA  pairs  incorporated  into  the  host  genome66,67.  These
transgenic  fish  can  utilize  p-azido-L-phenylalanine  (AzF)66 or  lysine
derivatives67 for protein synthesis in response to the amber stop codon. 
We have used our caged-cyclofen-OH/ERT system to activate a RS (AzFRS)
aiming to control the genetic code expansion scheme at the single cell level
and  to  alleviate  possible  long-term physiological  impairment  to  zebrafish
resulting from global or constitutive suppression of genomic stop codons. In
preliminary  experiments  with  cell  cultures,  we  have  seen  that  a  fusion
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between AzFRS and ERT could indeed be activated by cyclofen-OH to initiate
amber suppression and AzF incorporation.
The  previous  examples  demonstrate  the  variety  of  applications  and
usefulness  of  the  caged-cyclofen-OH/ERT  approach,  which  provides  for  a
generic approach to the control of protein activity and gene expression in a
variety of physiological contexts and animal models. 
Fig.4: Examples of the use of the caged-cyclofen-OH/ERT system in a variety 
of physiological contexts. (A-C) transient activation of an oncogene 
(kRasG12V), see Fig.3(a-c), in a zebrafish embryo does not lead to cancer. 
On the other hand permanent induction (D-F, see also Fig.3(d-f)) can lead to 
tumorigenesis as demonstrated by the tumor growth (D) and the presence of
the oncogene marker (CFP, F). In the context of development permanent 
activation of Fgf8 yields to an increase in the concentration of the protein 
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and its fluorescent marker (CFP) during somitogenesis with observable 
phenotypic consequences (G) and in particular a shortening of the somite 
size. (H). Adapted from Feng et al.55.
CONCLUSIONS
In this article, we have described a generic and versatile approach to the 
control of gene expression and protein activity in a live animal at the level of 
a single cell, and with temporal resolution of a few seconds. This approach 
builds on the well-established conditional ERT/tamoxifen-OH genetic 
induction system. That approach has been used to induce the activation of 
specific genes (permanently using a Cre-ERT/loxP or transiently using a Gal-
ERT/UAS system) in different organisms (zebrafish, mice, fly, etc.). The 
conditional activation of many proteins has also been achieved by fusing 
them with the ERT peptide. Thus many transgenic lines of various organisms 
exist that allow for this conditional activation globally or locally in specific 
tissues. We have shown that the use of caged cyclofen-OH  together with a 
well-established conditional expression system can be utilized to induce 
rapid activation of genes and proteins at the single cell level in a live 
organism. On the basis of the similarity between our ligand and other 
steroids, we believe that similar results could be obtained with other caged 
steroids of the same family (estradiol, tamoxifen-OH, etc.).
The main advantage of the  approach sketched here is its versatility and 
ease of implementation within an existing context of appropriate transgenic 
lines. It allows for fast activation (with a few seconds of illumination) at 
intensities and wavelengths that are not detrimental to the cell. Its main 
drawbacks are:
1)  The lack of control on the time lapse of activation (once the caged 
steroid is photo-activated it cannot be de-activated). Transient 
activation relies on the steroid unbinding from the ERT peptide and its 
diffusion out of the induced cell(s) within an ill-controlled timescale 
(typically a few hours). This is in contrast with some photo-activable 
proteins which dimerization can be induced and reversed by 
illumination at appropriate wavelengths.  
2) The lack of sub-cellular control. Once released  the steroid diffuses 
throughout and out of the cell (though the protein-ERT construct may 
be targeted to specific organelle). This is in contrast with some photo-
activable proteins which dimerization can be induced locally within a 
cell. 
Nonetheless, we believe that the caged-cyclofen-OH/ERT system provides an
alternative and complementary approach to the optogenetic methods that 
rely on photo-induced conformational changes in some proteins to control 
the activity of their fused partner.
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